Email Editor Last month’s gossip has become this month’s headline news. Two rumors in the pharma industry, which were noted in last month’s issue, have now materialized as full-fledged deals. Both reflect the ongoing attractiveness of consumer products and generic...
Email Editor Mega-deals, among their many attractions, are interesting because of the way they may change the landscape of an industry. By all rights, Thermo Electron Corporation’s (NYSE: TMO) proposed $12.8 billion acquisition of Fisher Scientific International, Inc....
Email Editor The month of April saw a surge of dealmaking in the Medical Device sector, with a total of 14 transactions announced. Based on revealed prices, the total amount spent to fund this activity was $4.7 billion, or 59% of all M&A dollars spent during the...
Europe Sees A Flurry of Springtime Dealmaking In The Pharmaceutical Industry, As Bayer Leads The Pack With A $19.5 Billion Bid for Schering AG March saw a surge of M&A activity in the pharmaceutical sector, particularly in Europe. A total of 17 deals were...
Email Editor Knowing when to hold ‘em and knowing when to fold ‘em are useful skills in more games than just poker. The bidding war for Guidant Corporation (NYSE: GDT), raging over the past two months, has finally come to an end with Guidant’s board accepting Boston...
Email Editor The fourth quarter of 2005 saw a total of 221 mergers and acquisitions in 13 sectors of the health care industry. This represents a 13% decrease from the 253 deals in the previous quarter, but a 2% increase over the 217 deals in the year-ago quarter,...